David Paling

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Randomized Controlled Trial

Stem Cell Transplantation

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Gavin Brittain, Jennifer Petrie, Kate E M Duffy, Rachel Glover, Katie Hullock, Diana Papaioannou, Elisa Roldán, Colette Beecher, Matthew Bursnall, Olga Ciccarelli, Alasdair J Coles, Cindy Cooper, Gavin Giovannoni, Ian Gabriel, Majid Kazmi, Charalampia Kyriakou, Richard Nicholas, David Paling, Andy Peniket, Neil Scolding, Eli Silber, Thushan I de Silva, Annalena Venneri, Stephen J Walters, Carolyn Anne Young, Paolo A Muraro, Basil Sharrack, John A Snowden, null null
Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial. BMJ open 14 (2) (2024)
Danka Jandric, Ilona Lipp, David Paling, David Rog, Gloria Castellazzi, Hamied A Haroon, Laura Michelle Parkes, Geoffrey J M Parker, Valentina Tomassini, Nils Muhlert
Mechanisms of Network Changes in Cognitive Impairment in Multiple Sclerosis. Neurology 97 (19) (2021)